PL445753A1 - Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie - Google Patents

Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie

Info

Publication number
PL445753A1
PL445753A1 PL445753A PL44575323A PL445753A1 PL 445753 A1 PL445753 A1 PL 445753A1 PL 445753 A PL445753 A PL 445753A PL 44575323 A PL44575323 A PL 44575323A PL 445753 A1 PL445753 A1 PL 445753A1
Authority
PL
Poland
Prior art keywords
benzyloxycarbonylamino
amidino
naphthyl
ester hydrochloride
methylcarboxy
Prior art date
Application number
PL445753A
Other languages
English (en)
Inventor
Ewa Burchacka
Original Assignee
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska filed Critical Politechnika Wrocławska
Priority to PL445753A priority Critical patent/PL445753A1/pl
Publication of PL445753A1 publication Critical patent/PL445753A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metano-fosfonowego o wzorze 1 i jego zastosowanie jako środka przeciwbakteryjnego do eliminowania bakterii Serratia marcescens.
PL445753A 2023-08-03 2023-08-03 Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie PL445753A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445753A PL445753A1 (pl) 2023-08-03 2023-08-03 Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445753A PL445753A1 (pl) 2023-08-03 2023-08-03 Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie

Publications (1)

Publication Number Publication Date
PL445753A1 true PL445753A1 (pl) 2025-02-10

Family

ID=94479885

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445753A PL445753A1 (pl) 2023-08-03 2023-08-03 Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie

Country Status (1)

Country Link
PL (1) PL445753A1 (pl)

Similar Documents

Publication Publication Date Title
EP4491199A3 (en) Gadolinium bearing pcta-based contrast agents
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
BR0316606A (pt) Derivados de aminoindazóis e sua utilização como inibidores de quinases
GEP20267862B (en) Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof
EA200400073A1 (ru) Пирролопиримидины как ингибиторы протеинкиназы
BR112018009297A8 (pt) composição de limpeza e desinfecção
BR0010555A (pt) Inibidores de neuraminidases
CR20230485A (es) Derivados de fósforo como nuevos inhibidores de sos1
UY25780A1 (es) Nuevos antibióticos macrólidos
ZA202301937B (en) Compounds
CR10974A (es) Inhibidores de carboxipeptidasa b plasmatica (divisional)
CY1108498T1 (el) Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινη
MX2022015679A (es) Inhibidor de tyk-2.
EA200401183A1 (ru) Применение ингибиторов il-18 в качестве диагностического маркера
MX2025012370A (es) Compuesto de amida, composicion farmaceutica que comprende el compuesto y uso de esta
MX2024010712A (es) Sal de cabozantinib con ácido l-(+)-tartárico y formas sólidas de esta
MX2024015922A (es) Degradadores de proteinas del factor 2 relacionado con el eritroide de factor nuclear 2 (nrf2)
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
PL445753A1 (pl) Chlorowodorek estru p-metylokarboksy-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie
ATE187461T1 (de) Cyklopeptolide
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
PL445752A1 (pl) Chlorowodorek estru p-merkaptometylo-diarylowego kwasu benzyloksykarbonylamino-[(6-amidyno)naftylo]metanofosfonowego oraz jego zastosowanie
MX2024003859A (es) Inhibidores de lpxc y usos de estos.
MX2022011593A (es) Formas cristalinas de un compuesto farmaceutico.
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases